Zobrazeno 1 - 10
of 143
pro vyhledávání: '"Michelle Martinot-Peignoux"'
Publikováno v:
In Hepatology 2001 34(4) Part 2:A228-A228
Publikováno v:
In Hepatology 2001 34(4) Part 2:A602-A602
Autor:
Emilie Estrabaud, Kevin Appourchaux, Ivan Bièche, Fabrice Carrat, Martine Lapalus, Olivier Lada, Michelle Martinot-Peignoux, Nathalie Boyer, Patrick Marcellin, Michel Vidaud, Tarik Asselah
Publikováno v:
PLoS ONE, Vol 10, Iss 4, p e0121395 (2015)
Although, the treatment of chronic hepatitis C (CHC) greatly improved with the use of direct antiviral agents, pegylated-interferon (PEG-IFN) plus ribavirin remains an option for many patients, worldwide. The intra-hepatic level of expression of inte
Externí odkaz:
https://doaj.org/article/53a58c5073bc40cca8297d80aca14673
Autor:
Olav Dalgard, Michelle Martinot-Peignoux, Hans Verbaan, Kristian Bjøro, Helmer Ring-Larsen, Patrick Marcellin
Publikováno v:
PLoS ONE, Vol 10, Iss 8, p e0120866 (2015)
The aim of this study was to determine in patients with HCV genotype 2 or 3 the performance at week 4 of two assays with different sensitivities for HCV RNA detection, for the prediction of SVR and stratification for treatment duration (14 and 24 wee
Externí odkaz:
https://doaj.org/article/431d0c2ca5fe41d7a2269d9905295e38
Autor:
Michèle Pouteau, Corinne Castelnau, Patrick Marcellin, N. Giuily, Nathalie Boyer, Rami Moucari, Sarah Maylin, Tarik Asselah, Michelle Martinot-Peignoux, M. Lapalus
Publikováno v:
Journal of Viral Hepatitis. 23:905-911
Quantitative hepatitis B core-related antigen (qHBcrAg) has been proposed as an additional marker to quantitative HBsAg (qHBsAg), for management of chronic hepatitis B. Evaluate baseline combination of qHBsAg and qHBcrAg for identification of patient
Publikováno v:
Liver International. 36:78-84
Molecular biology techniques are routinely used to diagnose and monitor treatment in patients with chronic hepatitis B (CHB). These tools can detect and quantify viral genomes and analyse their sequences to determine genotype. The increasing use of t
Autor:
S. De Muynck, Olivier Lada, E. Estrabaud, Cédric Laouénan, M. Lapalus, Pierre Bedossa, Michelle Martinot-Peignoux, Nathalie Boyer, Patrick Marcellin, Michel Vidaud, Q. Zhang, Tarik Asselah, Ivan Bièche, Rami Moucari
Publikováno v:
Journal of Viral Hepatitis. 21:525-532
The impact of IFNL3 (IL28B) polymorphism on response to interferon (IFN) treatment in patients infected with hepatitis B virus (HBV) is controversial. We aimed to investigate whether IFNL3 polymorphism (rs12979860) influences the long-term response o
Autor:
Roberto J. Carvalho-Filho, Nathalie Boyer, Marie Pierre Ripault, M. Lapalus, Olivier Lada, Patrick Marcellin, Cédric Laouénan, Tarik Asselah, Ana Carolina Ferreira Netto-Cardoso, Michelle Martinot-Peignoux
Publikováno v:
Journal of Clinical Virology. 58:401-407
Differentiating 'inactive carriers' (ICs) of hepatitis B virus (HBV) from hepatitis B e antigen-negative (HBeAg[-]) patients in remission is challenging. We investigated whether serum-based monitoring of hepatitis B surface antigen (HBsAg) and HBV-DN
Publikováno v:
Clinics in Liver Disease. 17:399-412
There is a growing interest in serum HBsAg quantification (qHbsAg). HBsAg titers are negatively correlated with liver fibrosis in HBeAg(+) patients. In HBeAg(-) HBsAg level
Autor:
Olivier Lada, Roberto J. Carvalho-Filho, Friedemann Krause, M. Lapalus, Patrick Marcellin, Tarik Asselah, Richard Batrla, Michelle Martinot-Peignoux, Ana Carolina Ferreira Netto-Cardoso
Publikováno v:
Journal of Hepatology. 58:1089-1095
Little is currently known about the association between serum HBsAg or HBV DNA levels and the severity of liver disease in chronic hepatitis B (CHB) patients. Therefore, we investigated these relationships in a large cohort of unselected, well-charac